Pharmacotypes across the genomic landscape of pediatric acute lymphoblastic leukemia and impact on treatment response
2023 · Nature Medicine · 92 citations
https://doi.org/10.1038/s41591-022-02112-7
A
August John
Mayo Clinic(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
22
Papers
392
Citations
8
h-index
7
i10-index
August John is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Acute Lymphoblastic Leukemia research & Acute Myeloid Leukemia Research & Computational Drug Discovery Methods. The author has an h-index of 8, co-authored 19 publications.
ORCID: 0000-0003-4615-9474Papers by this author
worksTRAF4 hyperactivates HER2 signaling and contributes to Trastuzumab resistance in HER2-positive breast cancer
2022 · Oncogene · 35 citations
https://doi.org/10.1038/s41388-022-02415-6
Lestaurtinib’s antineoplastic activity converges on JAK/STAT signaling to inhibit treatment naïve and therapy resistant forms ovarian cancer
2025 · npj Precision Oncology · 1 citations
https://doi.org/10.1038/s41698-025-00947-0
CO55 Incidence of Adverse Events with Pembrolizumab in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Systematic Review of Literature
2024 · Value in Health · 0 citations
https://doi.org/10.1016/j.jval.2024.03.144
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat